Literature DB >> 18504503

Natural history of chronic hepatitis B - clinical implications.

Brian J McMahon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18504503      PMCID： PMC2390714     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN： 1934-1997


× No keyword cloud information.
  18 in total

Review 1.  Hepatitis B e antigen-negative chronic hepatitis B.

Authors:  S J Hadziyannis; D Vassilopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 2.  Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

Authors:  Scott K Fung; Anna S F Lok
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

3.  A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.

Authors:  F Donato; P Boffetta; M Puoti
Journal:  Int J Cancer       Date:  1998-01-30       Impact factor: 7.396

4.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

5.  Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations.

Authors:  Tomoyuki Sakamoto; Yasuhito Tanaka; Josephine Simonetti; Carla Osiowy; Malene L Borresen; Anders Koch; Fuat Kurbanov; Masaya Sugiyama; Gerald Y Minuk; Brian J McMahon; Takashi Joh; Masashi Mizokami
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

6.  Hepatitis B virus genotypes in the United States: results of a nationwide study.

Authors:  Chi-Jen Chu; Emmet B Keeffe; Steven-Huy Han; Robert P Perrillo; Albert D Min; Consuelo Soldevila-Pico; William Carey; Robert S Brown; Velimir A Luketic; Norah Terrault; Anna S F Lok
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

7.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection.

Authors:  A S Lok; C L Lai; P C Wu; E K Leung; T S Lam
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

8.  Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

Authors:  Chi-Jen Chu; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

Authors:  A S Lok; R H Liang; E K Chiu; K L Wong; T K Chan; D Todd
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

Authors:  H L-Y Chan; A Y Hui; M L Wong; A M-L Tse; L C-T Hung; V W-S Wong; J J-Y Sung
Journal:  Gut       Date:  2004-10       Impact factor: 23.059
View more
  23 in total

1.  Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort.

Authors:  Kwesi Z Tandoh; Kwadwo A Kusi; Timothy N Archampong; Isaac Boamah; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-29

Review 2.  Exploring Hepatitis From the Perspective of Iranian Traditional Medicine: Using a Qualitative Approach.

Authors:  Mahdi Yousefi; Seyed Mous Al-Reza Hosseini; Ali Taghipour; Saeed Zibaee; Mohammad Reza Noras
Journal:  J Evid Based Complementary Altern Med       Date:  2016-06-22

3.  Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan.

Authors:  Hani A Masaadeh; Wail A Hayajneh; Enayat A Alqudah
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

4.  Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

Authors:  Elisabeth Smolle; Evelyn Zöhrer; Kira Bettermann; Johannes Haybaeck
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

5.  Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.

Authors:  Papa Saliou Mbaye; Anna Sarr; Jean-Marie Sire; Marie-Louise Evra; Adama Ba; Jean Daveiga; Aboubakry Diallo; Fatou Fall; Loic Chartier; François Simon; Muriel Vray
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

6.  The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran.

Authors:  Farhad Fathimoghaddam; Mohammad Reza Hedayati-Moghaddam; Hamid Reza Bidkhori; Sanaz Ahmadi; Hamid Reza Sima
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

7.  Hepatitis B virus antibody levels in high-risk health care workers.

Authors:  Esmaeil Mohammad Nejad; Sirous Jafari; Mahmood Mahmoodi; Jamaloddin Begjani; Seyyedeh Roghayyeh Ehsani; Narmela Rabirad
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660

8.  Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.

Authors:  Sarah Maylin; Jean-Marie Sire; Papa Saliou Mbaye; François Simon; Anna Sarr; Marie-Louise Evra; Fatou Fall; Jean Daveiga; Aboubakry Diallo; Jean-Marc Debonne; Loic Chartier; Muriel Vray
Journal:  BMC Infect Dis       Date:  2015-03-25       Impact factor: 3.090

9.  Clinical outcome of a patient cohort with acute hepatitis B.

Authors:  Laura Alves de Souza; Angelo Alves de Mattos; Maristela Fiorini; Polyanna Ribeiro; Cristiane Valle Tovo
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

10.  Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study.

Authors:  Alireza Ansari-Moghaddam; Mohammad Reza Ostovaneh; Batool Sharifi Mood; Esmail Sanei-Moghaddam; Amirhossein Modabbernia; Hossein Poustchi
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.